Gelonghui, Feb. 27丨Zhonghui Healthcare (300981.SZ) announced that from January 12, 2024 to February 8, 2024, the closing price of Zhonghong Pulin Medical Products Co., Ltd. (“Company”) stock closing price has fallen below 15.1,519 yuan/share for 20 consecutive trading days. According to the company's “Plan to stabilize the company's stock price within three years after stock listing”, the conditions for triggering measures to stabilize stock prices have been met. In order to fulfill the promise to stabilize the stock price, and based on the judgment of the company's value and confidence in future development, it is planned to use its own funds to repurchase the company's shares through centralized bidding transactions, which are necessary to maintain the company's value and shareholders' rights and interests.
The types of shares repurchased are RMB common shares (A shares) already issued by the company. The shares repurchased are necessary to maintain the company's value and shareholders' rights. The company's total share repurchase capital is not less than RMB 6,650,850 (including capital), not higher than RMB 13,300,003 (including capital), the upper limit of the repurchase amount is not higher than 20% of the most recent audited net profit and the upper limit is not more than 2 times the lower limit, and the repurchase price is not more than RMB 15.15 per share (including capital). According to the upper limit of the repurchase price and the lower limit of the repurchase amount, the estimated number of shares that can be repurchased is 439,000 shares, accounting for 0.113% of the company's total share capital after excluding the shares in the special account; according to the upper limit of the repurchase price and the upper limit of the repurchase amount, the estimated number of shares that can be repurchased is 877,888 shares, accounting for about 0.225% of the company's total share capital after excluding the shares in the special repurchase account. The amount and quantity of shares to be repurchased is based on the actual number of shares repurchased at the end of the repurchase period. The implementation period for the share repurchase is within three months from the date the first extraordinary shareholders' meeting of the company reviewed and approved the repurchase plan in 2024.
